1.
Recent Advancements in Ex Vivo CRISPR/Cas9 Gene Editing for Hemoglobinopathies: A Systematic Review of Clinical and Preclinical Progress. Al-Shatrah Veterinary and Biological Sciences Journal. 2026;2(3):98-113. Accessed October 3, 2026. https://svbsj.shu.edu.iq/index.php/svbsj/article/view/69